Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Free Light Chains in Heart Failure
Author(s): Akira Matsumori , Toshio Shimada , Hisayoshi Suma , et al Added: 6 days ago

Heart Failure
GLP-1 RAs in T2D and Established or High-risk ASCVD
Author(s): Wanwarang Wongcharoen , Rungroj Krittayaphong , Wacin Buddhari , et al Added: 1 year ago

Cardiovascular Kidney Metabolic

Prevention & Chronic Conditions
ESC HF 25: CRISPR in ATTR-CM: Hereditary vs Wild-Type
Author(s): Marianna Fontana Added: 1 year ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,… View more

Heart Failure
Digital Therapeutics and Type 2 Diabetes
Author(s): Kayo Waki , Shuya Iwata , Toshimasa Yamauchi , et al Added: 1 year ago

Cardiovascular Kidney Metabolic
Hypertension and Abnormal Renal Function in Type-1 EHRA Valvular AF
Author(s): Rena Winant , Sunu Budhi Raharjo , Rina Ariani , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Importance of Testing for CKD Among Patients With Type 2 Diabetes
Author(s): Pam Taub , Nikolaus Marx Added: 1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical… View more

Guidelines & Statements

Prevention & Chronic Conditions
COVID-19 and Acute Aortic Dissection: Early Outcomes
Author(s): An Thai Nguyen , Hau Tien Nguyen , Vu Tuan Le Added: 1 month ago

Intervention

Vascular Disease and Surgery
GLP-1RAs Cut Cardiorenal Events in Type 1 Diabetes
Added: 2 months ago Source:  Radcliffe CVRM
While glucagon-like peptide-1 receptor agonists (GLP-1RAs) have established cardiorenal benefits in type 2 diabetes, long-term data for their use in patients with type 1 diabetes (T1D) have been scarce. A new large-scale study suggests that initiating GLP-1RA therapy is associated with a lower risk of major adverse cardiovascular and kidney outcomes in this population, without compromising safety… View more

Cardiovascular Kidney Metabolic

Heart Failure
ASD in Pregnancy and the 2025 ESC Guidelines
Author(s): Grace Hoi Ting Kwok , Kevin Ka-ho Kam Added: 1 month ago

Imaging & Diagnostics

Inherited and Congenital Cardiac Conditions
ADA 25: MariTide Treatment for Obesity in Patients with or without T2D
Author(s): Harold Bays Added: 11 months ago
ADA 2025 - Once-monthly MariTide treatment demonstrates around 15% average weight reduction at 52 weeks in patients with obesity, with or without type 2 diabetes.We are joined by Dr Harold Bays (L-MARC Research Center, Louisville, US) to discuss a 52-week, placebo-controlled, phase 2 randomised study (NCT05669599) investigating the efficacy, safety and tolerability of different doses of once… View more

Cardiovascular Kidney Metabolic